Christopher Weinert

Christopher Weinert has extensive work experience in the field of biopharmaceuticals. Christopher began their career as a PHD Graduate Student at the University of Zurich, where their research focused on the structural and functional characterization of TRIM20. Christopher then worked as a Research Scientist at the same institution. Following this, they joined ESBATech, a Novartis company, as a Scientist II, where they implemented biophysical screens and designed formulation experiments for lead candidate evaluation. Christopher also conducted stability studies for formulation development. Subsequently, they joined the Novartis Institutes for BioMedical Research (NIBR) as a Scientist II, where they specialized in scaffold and developability. At NIBR, they also completed an internship in Pharma Development. Currently, they are the Associate Director - Formulation & Analytics at Numab Therapeutics AG.

Christopher Weinert earned their Matura degree from Kantonsschule am Burggraben, St. Gallen in the years 1996-2001. Christopher then went on to pursue a Master of Science (M.Sc.) in Biochemistry from the University of Zurich from 2002-2007. Christopher furthered their education at the University of Zurich, Department of Biochemistry, where they obtained a Dr. sc. nat degree in Structural Biology from 2008-2013.